<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>Cancer Sciences</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E1F23693-3708-4C16-BA2A-4FB09770E685"><gtr:id>E1F23693-3708-4C16-BA2A-4FB09770E685</gtr:id><gtr:firstName>Syed</gtr:firstName><gtr:otherNames>Hasan</gtr:otherNames><gtr:surname>Arshad</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D3D3F76B-F553-4E47-8D35-A564C748B364"><gtr:id>D3D3F76B-F553-4E47-8D35-A564C748B364</gtr:id><gtr:firstName>Donna</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Davies</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F70BC32F-8A32-4BAB-BA6D-EC0C4E1E18AF"><gtr:id>F70BC32F-8A32-4BAB-BA6D-EC0C4E1E18AF</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:surname>Roberts</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A087746E-286E-423C-95D0-9E2838993CFF"><gtr:id>A087746E-286E-423C-95D0-9E2838993CFF</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Howarth</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FFADE489-5C2F-4860-A8CC-16981824D4E3"><gtr:id>FFADE489-5C2F-4860-A8CC-16981824D4E3</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Holgate</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C13A5B3F-C5E4-4282-B1E7-7C733030E467"><gtr:id>C13A5B3F-C5E4-4282-B1E7-7C733030E467</gtr:id><gtr:firstName>Philipp</gtr:firstName><gtr:otherNames>Johannes</gtr:otherNames><gtr:surname>Thurner</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900453"><gtr:id>844F3CD3-83C2-40A0-9913-31FC5020D071</gtr:id><gtr:title>A Life Course Approach to Investigating Asthma Pathogenesis and Progression</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900453</gtr:grantReference><gtr:abstractText>Asthma is the commonest chronic lung disease in the UK. It affects all age groups and significantly impacts on quality of life, schooling and work. For most it requires lifelong treatment with drugs and uncertainty, due to the variable nature of the disease. Little is known how factors initiate the disease in early life or impact over the life course of the disease. This programme is centred on studying the life course of asthma, focusing on underlying mechanisms that may lead to disease persistence and progression and how different environmental factors exert influence.
Our research focuses on the human asthma and involves sampling the airways to evaluate on-going tissue events and to obtain airway cells that can be studied in the laboratory under different conditions of exposure. We believe that the airways lining (epithelium) plays a major role in interacting with the environment and, in asthma, expresses signals that promote abnormal inflammation within the airways and induce structural changes (scarring) that alters their flexibility. We have called this dynamic interaction between the epithelium and the deeper airway wall structures the Epithelial Mesenchymal Trophic Unit (EMTU). Our research focuses on understanding how this EMTU is activated in asthma of differing severity and stages of disease. Recognising that most asthma has its origin in the first few years of life, undergoes major changes during childhood and adolescence in which over half ?grow out? of their diseases and adopts characteristics of becoming irreversible in some adults, we have constructed our 5 year programme in 3 stages: (i) In young children at the onset of disease we will use our cell culture systems in the presence and absence of virus, allergen and tobacco smoke exposure to seek differences in the way the epithelium communicates with underlying cells in the EMTU; ii) In teenagers from our Isle of Wight cohort, that has been extensively characterised in relationship to asthma from birth to the age of 18 years, we will assess activation of the EMTU in those with persistent asthma and those who have ?grown out? of asthma; and (iii) In adults with established asthma we determine how the scarring affects the stiffness of the airway wall and whether repeated airway narrowing contributes to and can account for the loss of treatment response in such asthmatics.
This research will identify much needed new targets in disease prevention and treatment high up in the causal disease pathways.</gtr:abstractText><gtr:technicalSummary>Asthma is an inflammatory disorder of the airways which undergo distinct structural and functional changes leading to variable airflow obstruction. It is amongst the commonest chronic conditions in Western countries affecting 1 in 7 children and 1 in 12 adults. Despite massive investment in research, few new treatments have emerged, current treatment being aimed at suppressing inflammation and symptoms without influencing the underlying causes. The purpose of this programme is to take a life-course view of asthma, the development of sub-phenotypes and their progression over time by combining epidemiological with functional and mechanistic studies in vivo and in vitro. Fundamental to our approach is the recognition that the disease begins most frequently in the first few years, involves multiple interacting environmental stimuli (including viruses, allergens and pollutants) and has a variable natural history. Our programme places the airway epithelium and its communication with the underlying mesenchyme (Epithelial Mesenchymal Trophic Unit) at the centre of asthma. To test this, we will study three age groups: (i) young children at the onset of disease focussing on the role of multiple insults on a susceptible epithelium; ii) teenagers from our Isle of Wight cohort that has been extensively phenotyped for asthma from birth to 18 years seeking evidence for persistent activation of the EMTU; and (iii) adults with established asthma focussing on disease chronicity due to structural changes driven by the EMTU.
 Using biopsies and epithelial brushings from well phenotyped subjects we will apply our culture systems of epithelial monolayer, differentiated epithelium, epithelium seeded with dendritic cells and epithelium grown over (myo)fibroblasts to recapitulate the EMTU using airway cells from groups (i) and (ii). Cultures will be exposed to rhinovirus and smoke extract as the most important early life exposures linked to asthma onset, and effects on barrier function, allergen penetration and innate immunity assessed. In adults, airway wall remodelling dominates more chronic asthma. We will use endobronchial fibrepotic fluorecence microscopy combined with IHC, atomic force microscopy (stiffness) and helium ion microscopy (ultrastructure) and relate these to collagen type and cross-linking. Because remodelling is a response to repeated distortion of the airways, we will examine the effect of cyclical strain on the EMTU using cells from well phenotyped patients with differing degrees disease severity and remodelling.
 This integrated programme brings together epidemiological and disease cohorts with detailed phenotyping and mechanistic studies to reveal new high level targets fundamental to disease pathogenesis and progression.</gtr:technicalSummary><gtr:fund><gtr:end>2016-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2158552</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>CASE PhD studentship</gtr:description><gtr:id>C39AC72B-4824-492D-B0EC-642AE368932F</gtr:id><gtr:impact>2 Poster presentations at the American Thoracic Society 2014:

 Jessica E Donaldson, Betty Shamji, Emily J Swindle, Matt E Edwards, Donna E Davies. Regulation Of Thymic Stromal Lymphopoietin Release From Human Bronchial Fibroblasts By Pro-Inflammatory Cytokines 

Jessica E Donaldson, Betty Shamji, Emily J Swindle, Matt E Edwards, Donna E Davies. Characterization Of The Thymic Stromal Lymphopoietin Response In Co-Cultures Of Human Bronchial Fibroblasts And Epithelial Cells</gtr:impact><gtr:outcomeId>54609833b26be5.05026284-1</gtr:outcomeId><gtr:partnerContribution>Expertise in epithelial cell models - UoS
Expertise in analytical methodologies- Novartis
Shared expertise in respiratory diseases</gtr:partnerContribution><gtr:piContribution>A joint PhD student working between Novartis Horsham and University of Southampton</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Think Tank with CAAT (Europe)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EDAF613C-0ED4-444A-83A0-857D81AE74BC</gtr:id><gtr:impact>WE have prepared a white paper on barrier models for the lung, skin and GI tract. Publication by end 2014.

Better understanding of the needs of industry academia and regulatory bodies.</gtr:impact><gtr:outcomeId>5460adf4a4d571.21425148</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.controlledreleasesociety.de/BioBarriers%202014%20-%20Program.pdf</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>499713</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>28D0FAC8-6CD0-42BF-8823-C5FF634A266C</gtr:id><gtr:outcomeId>GEcBq4wbM3M0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme Grant</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0900453 and G0900453-E01/1</gtr:fundingRef><gtr:id>A649B47C-864B-40AB-A164-A288A6ECDD6B</gtr:id><gtr:outcomeId>hCJVJZRFkmF0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre</gtr:department><gtr:description>NIHR BRC</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>F5DBC2C4-B646-49A3-B4E8-8739D79E9979</gtr:id><gtr:outcomeId>58c15f7a544cd7.38787591</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>146652</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>research contract</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Johnson &amp; Johnson</gtr:fundingOrg><gtr:id>CAE71E94-9A58-45B6-8939-B05E59B8FA10</gtr:id><gtr:outcomeId>56d9753e4cd7b8.98446205</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>219573</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Training Fellowship (MJ)</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>40440054-C087-4C0A-B5D7-293EF26785F9</gtr:id><gtr:outcomeId>56dab5f0803fa4.26498576</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>86116</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Non-animal models for asthma</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>21A4A2EB-5BB3-4D84-B621-746BD10DE09E</gtr:id><gtr:outcomeId>56d9591e9edf41.46831391</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>291765</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Medical Research Foundation</gtr:department><gtr:description>MRF/Asthma UK Research Grant (HMH)</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3026C6EB-61A6-4833-9518-7E4A95E4BC4E</gtr:id><gtr:outcomeId>56d9601e61a9a5.32352532</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Synairgen</gtr:companyName><gtr:description>Respiratory Drug discovery company as spin-out of university of Southampton</gtr:description><gtr:id>9C951767-A3E2-45FE-8B17-6687763927E9</gtr:id><gtr:impact>June 2014: Out licencing of inhaled IFN beta for asthma and COPD exacerbations $7.25 million up-front, $225 million milestone payments and 9-16% Royalties on final sales.</gtr:impact><gtr:outcomeId>54620541ed5ae1.75085689</gtr:outcomeId><gtr:yearCompanyFormed>2005</gtr:yearCompanyFormed></gtr:spinOutOutput><gtr:spinOutOutput><gtr:companyName>Synairgen</gtr:companyName><gtr:description>Synairgen is a respiratory drug development company</gtr:description><gtr:id>B8910B5D-AD77-4865-8EDD-94459ED677C9</gtr:id><gtr:impact>June 2014: AS
Southampton, UK: Synairgen plc (LSE: SNG) today announced a global licence agreement with AstraZeneca for SNG001, a novel, inhaled interferon beta (IFN -beta) in clinical development for treating respiratory tract viral infections in patients with severe asthma. SNG001supports the immune system by correcting a deficiency which makes patients vulnerable to respiratory tract viral infections. Under the terms of the exclusive
licence agreement, AstraZeneca will pay Synairgen a $7.25 million up - front fee and potential development, regulatory and commercial milestones
of up to $225million. In addition, AstraZeneca will pay tiered royalties ranging from single -digit up to mid - teens on commercial sales.
AstraZeneca will be responsible for future development costs. In early 2015, AstraZeneca will commence a Phase II a study in patients
with severe asthma building on available clinical data from an initial Phase ll a trial in a broad asthma population. SNG001 also provides the opportunity to expand the clinical programme in other pulmonary diseases including chronic obstructive pulmonary disease (COPD).</gtr:impact><gtr:outcomeId>54620467d74423.20292299</gtr:outcomeId><gtr:url>http://www.synairgen.com/</gtr:url><gtr:yearCompanyFormed>2005</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>CC47CAA6-91A3-4424-87A6-D720E2D86DE7</gtr:id><gtr:title>Low molecular weight components of pollen alter bronchial epithelial barrier functions.</gtr:title><gtr:parentPublicationTitle>Tissue barriers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b9d2cf18d6caad596bebc041d226187"><gtr:id>2b9d2cf18d6caad596bebc041d226187</gtr:id><gtr:otherNames>Blume C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2168-8362</gtr:issn><gtr:outcomeId>56d80299dab343.83659308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F6BB8A9-AC41-4AF6-B713-D2BD0D5AF4C2</gtr:id><gtr:title>The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1546-3222</gtr:issn><gtr:outcomeId>hMZAvyYbWZv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8664D15B-C179-4D78-BEA2-833B561FAB45</gtr:id><gtr:title>The interplay of DNA methylation over time with Th2 pathway genetic variants on asthma risk and temporal asthma transition.</gtr:title><gtr:parentPublicationTitle>Clinical epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bde23452702f3d087e5f35cb87dd0e1"><gtr:id>1bde23452702f3d087e5f35cb87dd0e1</gtr:id><gtr:otherNames>Zhang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1868-7075</gtr:issn><gtr:outcomeId>56d80722872a25.12466357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7679A94B-F87A-4269-866D-C16FF05E5001</gtr:id><gtr:title>Mast cells are permissive for rhinovirus replication: potential implications for asthma exacerbations.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af07647a653ddf6f6fa8176e5974d63e"><gtr:id>af07647a653ddf6f6fa8176e5974d63e</gtr:id><gtr:otherNames>Akoto C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>58c15a8f8a0752.70055497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>317638DE-56A9-4453-9855-C1361344076E</gtr:id><gtr:title>Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b6f494658b78d96a90ec56ac4571c03"><gtr:id>0b6f494658b78d96a90ec56ac4571c03</gtr:id><gtr:otherNames>Vijayanand P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56d80ea00be636.08173361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CFFFA1B-E4BF-4086-8BC7-4DF7880DB3F0</gtr:id><gtr:title>Infant lung function and wheeze in later childhood in the Southampton Women's Survey.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/578ce0b3c6e9c7e1f1c8243422efb930"><gtr:id>578ce0b3c6e9c7e1f1c8243422efb930</gtr:id><gtr:otherNames>Brooke E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>56d80724404318.73705988</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A031D26-53C3-4197-9B3F-AD5A69978CD1</gtr:id><gtr:title>Barrier responses of human bronchial epithelial cells to grass pollen exposure.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b9d2cf18d6caad596bebc041d226187"><gtr:id>2b9d2cf18d6caad596bebc041d226187</gtr:id><gtr:otherNames>Blume C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_15040_20_23143548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B629F580-8F4D-4D88-967F-07FE2F0CC916</gtr:id><gtr:title>MicroRNAs and respiratory diseases.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a293a2f83814805fb9e3fd25a429d6d"><gtr:id>2a293a2f83814805fb9e3fd25a429d6d</gtr:id><gtr:otherNames>Rupani H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>56d8118b663733.19228493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDC1C7ED-630B-453E-804F-881BE19E6603</gtr:id><gtr:title>Validation of novel wheeze phenotypes using longitudinal airway function and atopic sensitization data in the first 6 years of life: evidence from the Southampton Women's survey.</gtr:title><gtr:parentPublicationTitle>Pediatric pulmonology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9eb044c00e16b56f648b2598fce5b398"><gtr:id>9eb044c00e16b56f648b2598fce5b398</gtr:id><gtr:otherNames>Collins SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1099-0496</gtr:issn><gtr:outcomeId>56d807251a2572.48190976</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>350E00D3-8702-4532-B654-5D6B3EA85520</gtr:id><gtr:title>SAM-pointed domain ETS factor mediates epithelial cell-intrinsic innate immune signaling during airway mucous metaplasia.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf333778ece12fc1375723897b6bd5b8"><gtr:id>bf333778ece12fc1375723897b6bd5b8</gtr:id><gtr:otherNames>Korfhagen TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15040_20_23012424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0D6A898-3BF7-49A8-9EB8-619E689B3D16</gtr:id><gtr:title>Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d199504163267f11ec905f391f0c4525"><gtr:id>d199504163267f11ec905f391f0c4525</gtr:id><gtr:otherNames>Loxham M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>5aa7c67487f1e8.06466925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0F1C11A-D361-4AB7-95ED-64C2E2B31D75</gtr:id><gtr:title>Airway inflammation in atopic patients: a comparison of the upper and lower airways.</gtr:title><gtr:parentPublicationTitle>Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e178dbb5f74fe6d1c049796e08119a1"><gtr:id>8e178dbb5f74fe6d1c049796e08119a1</gtr:id><gtr:otherNames>Bhimrao SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0194-5998</gtr:issn><gtr:outcomeId>56d80e9fabe621.73708752</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD2BE153-5956-4FA5-8157-634E6447B14B</gtr:id><gtr:title>A new look at the pathogenesis of asthma.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>ezz3wQ4VNm7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6E99BD1-9090-4B26-96C2-8F4F63019112</gtr:id><gtr:title>Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12df2ac4e1f46f87465e17ed18f05e7c"><gtr:id>12df2ac4e1f46f87465e17ed18f05e7c</gtr:id><gtr:otherNames>Green BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f985985123ddbd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97C37D98-0E98-4081-A4F9-9E9B59EE6EF9</gtr:id><gtr:title>Tissue factor-bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in&amp;nbsp;vitro and in&amp;nbsp;vivo.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de91105e42bdf267944b020828390242"><gtr:id>de91105e42bdf267944b020828390242</gtr:id><gtr:otherNames>Park JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56d8118b3c4c50.52485740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>374C83D8-87C3-4AF2-9102-22B812FC713C</gtr:id><gtr:title>Airway remodelling in asthma and novel therapy.</gtr:title><gtr:parentPublicationTitle>Asian Pacific journal of allergy and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df6218fdbbdd96ccbd9e67e22d1b5ae3"><gtr:id>df6218fdbbdd96ccbd9e67e22d1b5ae3</gtr:id><gtr:otherNames>Manuyakorn W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0125-877X</gtr:issn><gtr:outcomeId>pm_15040_20_23517388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75D43B8D-5922-4DFD-97EE-BBBEC74972B4</gtr:id><gtr:title>Geographical variation in the prevalence of sensitization to common aeroallergens in adults: the GA(2) LEN survey.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51149cca579856ffb89013a47cf7fa9"><gtr:id>d51149cca579856ffb89013a47cf7fa9</gtr:id><gtr:otherNames>Newson RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>56d8118ab569c4.45808182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CD6887E-6E5B-43CE-BFF9-76D91F5BF13C</gtr:id><gtr:title>Barrier disrupting effects of alternaria alternata extract on bronchial epithelium from asthmatic donors.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c2a9a2dc87f93d0c9d1f29b934b3161"><gtr:id>7c2a9a2dc87f93d0c9d1f29b934b3161</gtr:id><gtr:otherNames>Leino MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15040_20_24009658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7E8DD63-E990-45C4-863C-6018398B5788</gtr:id><gtr:title>Epithelial function and dysfunction in asthma.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d199504163267f11ec905f391f0c4525"><gtr:id>d199504163267f11ec905f391f0c4525</gtr:id><gtr:otherNames>Loxham M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>54620aca0a34e8.56677705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6611AAE2-6345-4492-80FF-D23FC13E2435</gtr:id><gtr:title>Structure-mechanics relationships of collagen fibrils in the osteogenesis imperfecta mouse model.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f613c8710a83a1650257a70e25afa3c1"><gtr:id>f613c8710a83a1650257a70e25afa3c1</gtr:id><gtr:otherNames>Andriotis OG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>56d95636244d57.51138530</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7A95194-46C4-40F5-BB3E-784066D216F4</gtr:id><gtr:title>A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e0139d19d0f91588edb2f39241fbfe1"><gtr:id>3e0139d19d0f91588edb2f39241fbfe1</gtr:id><gtr:otherNames>B?nnelykke K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>546209cf1bba90.92885881</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA9CF57C-F272-455A-97B5-CD33F6C0A1AD</gtr:id><gtr:title>Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f59e58738a90493179d2cbcfa849c8f"><gtr:id>0f59e58738a90493179d2cbcfa849c8f</gtr:id><gtr:otherNames>Bousquet J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56d80722b5f255.96085010</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0683BCCB-C9C3-47D3-AEAF-A76B483804C7</gtr:id><gtr:title>HHIP, HDAC4, NCR3 and RARB polymorphisms affect fetal, childhood and adult lung function.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9eb044c00e16b56f648b2598fce5b398"><gtr:id>9eb044c00e16b56f648b2598fce5b398</gtr:id><gtr:otherNames>Collins SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>56d809a65a1b50.58027875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87DC71DB-AA77-48B1-9B70-A8FC97E1A6B9</gtr:id><gtr:title>Pollen metabolome analysis reveals adenosine as a major regulator of dendritic cell-primed T(H) cell responses.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11d2720bfdb1918762811fa89dea5685"><gtr:id>11d2720bfdb1918762811fa89dea5685</gtr:id><gtr:otherNames>Gilles S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56d80e9f11b230.85736239</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84169DA9-740A-4C76-9FBD-884CD0B1A54F</gtr:id><gtr:title>Pathways activated during human asthma exacerbation as revealed by gene expression patterns in blood.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdb919fc36ca86fe4d9d3007a67a749f"><gtr:id>fdb919fc36ca86fe4d9d3007a67a749f</gtr:id><gtr:otherNames>Bjornsdottir US</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d8118c21e349.08046100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B50F05E5-7178-4B27-B219-E56EF7FCA202</gtr:id><gtr:title>Preterm birth, infant weight gain, and childhood asthma risk: a meta-analysis of 147,000 European children.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8134b74e04aa7a48f38b3c9b6744574e"><gtr:id>8134b74e04aa7a48f38b3c9b6744574e</gtr:id><gtr:otherNames>Sonnenschein-van der Voort AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56d80722e3f443.83297015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBAD11B4-315D-4D97-82DA-1BDEA1B8888E</gtr:id><gtr:title>Temporal Monitoring of Differentiated Human Airway Epithelial Cells Using Microfluidics.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b9d2cf18d6caad596bebc041d226187"><gtr:id>2b9d2cf18d6caad596bebc041d226187</gtr:id><gtr:otherNames>Blume C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d8029a0cfad2.13078765</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>158AB2FE-5965-410F-A498-EB0287718E38</gtr:id><gtr:title>Autocrine ligands of the epithelial growth factor receptor mediate inflammatory responses to diesel exhaust particles.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bef0948b2740deed330bb55c113e1b33"><gtr:id>bef0948b2740deed330bb55c113e1b33</gtr:id><gtr:otherNames>Parnia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn><gtr:outcomeId>5461f9c77380b0.14614833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E6D51B4-E9EF-4E61-A691-86605D3752B2</gtr:id><gtr:title>Does exposure to indoor allergens contribute to the development of asthma and allergy?</gtr:title><gtr:parentPublicationTitle>Current allergy and asthma reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a186912c86b964f39153b5b6620edbb"><gtr:id>9a186912c86b964f39153b5b6620edbb</gtr:id><gtr:otherNames>Arshad SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1529-7322</gtr:issn><gtr:outcomeId>56d807237a5de8.56389742</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>080D59C3-7F4D-45AA-B219-C6CD0F6FE8B2</gtr:id><gtr:title>Innate and adaptive immune responses in asthma.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a7699236df16c024620ef8aa26b259"><gtr:id>13a7699236df16c024620ef8aa26b259</gtr:id><gtr:otherNames>Holgate ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>pm_15040_20_22561831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6526A4F8-96A6-4D60-962F-F0DA1013A500</gtr:id><gtr:title>Health experiences of adolescents with uncontrolled severe asthma.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86505d7a183059ae85e23ba92811d535"><gtr:id>86505d7a183059ae85e23ba92811d535</gtr:id><gtr:otherNames>Edgecombe K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>56d80725945ca4.51253625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2499FF3B-96F2-445A-BD64-AD57FFEE668A</gtr:id><gtr:title>Preliminary study of the cellular characteristics of primary bronchial fibroblasts in patients with asthma: expression of alpha-smooth muscle actin, fibronectin containing extra type III domain A, and smoothelin.</gtr:title><gtr:parentPublicationTitle>Journal of investigational allergology &amp; clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d123369d53cdf39641ff33148e9c4a58"><gtr:id>d123369d53cdf39641ff33148e9c4a58</gtr:id><gtr:otherNames>Nam YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1018-9068</gtr:issn><gtr:outcomeId>pm_15040_20_22448450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B8D399B-5819-4842-BFEE-C0ABFE1EC0E4</gtr:id><gtr:title>Function of the airway epithelium in asthma.</gtr:title><gtr:parentPublicationTitle>Journal of allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e335c0000ea3fe39aef9f9c5633b0c7c"><gtr:id>e335c0000ea3fe39aef9f9c5633b0c7c</gtr:id><gtr:otherNames>Hallstrand TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1687-9783</gtr:issn><gtr:outcomeId>pm_15040_20_22536273</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B828C21-DEAC-4ED1-A945-6AA5F9231CAB</gtr:id><gtr:title>Inhibition of Pim1 kinase, new therapeutic approach in virus-induced asthma exacerbations.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da15b7d64b238ed82fa75a6db647f1e3"><gtr:id>da15b7d64b238ed82fa75a6db647f1e3</gtr:id><gtr:otherNames>Vries Md</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>56d94dc2dad100.26000917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82559D53-EAB8-484F-A80B-0832D999AC72</gtr:id><gtr:title>The association of the cytoplasmic domains of interleukin 4 receptor alpha and interleukin 13 receptor alpha 2 regulates interleukin 4 signaling.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfa5191c9373100e1dac544ca1a2e4b1"><gtr:id>bfa5191c9373100e1dac544ca1a2e4b1</gtr:id><gtr:otherNames>Andrews AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>pm_15040_20_24056919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EBDDB99-3B59-41F0-A4F7-5880D8160847</gtr:id><gtr:title>Effect of bronchoconstriction on airway remodeling in asthma.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b31ee767a89f08cb389e49db9b828f4"><gtr:id>6b31ee767a89f08cb389e49db9b828f4</gtr:id><gtr:otherNames>Grainge CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>56d80e9f66dee8.42158771</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9494E96A-5E00-4F8B-A065-54D821BBE60E</gtr:id><gtr:title>Dusting the cause for the time trends in asthma.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29b24514be53daa72546a54842fe018a"><gtr:id>29b24514be53daa72546a54842fe018a</gtr:id><gtr:otherNames>Patil VK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>56d80723253010.99442522</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32B41222-74B6-49FC-BF44-2578D84294BC</gtr:id><gtr:title>Rhinovirus-16 induced release of IP-10 and IL-8 is augmented by Th2 cytokines in a pediatric bronchial epithelial cell model.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdf236abadd59c50f2a6319fb59a6457"><gtr:id>bdf236abadd59c50f2a6319fb59a6457</gtr:id><gtr:otherNames>Cakebread JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5461fa11346477.97665821</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA0DC106-808B-454C-A9E0-56493312B159</gtr:id><gtr:title>Biocompatibility of poly(2-alkyl-2-oxazoline) brush surfaces for&amp;nbsp;adherent lung cell lines.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12164d38df714a515fb82c633a09a62d"><gtr:id>12164d38df714a515fb82c633a09a62d</gtr:id><gtr:otherNames>Tait A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>56d8029a3aa364.70572788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58C426BE-8016-4CEA-9BE4-C306A51F2CC4</gtr:id><gtr:title>Oral contraceptives modify the effect of GATA3 polymorphisms on the risk of asthma at the age of 18&amp;nbsp;years via DNA methylation.</gtr:title><gtr:parentPublicationTitle>Clinical epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81a1488649be91d706a6fb1f2eea7f64"><gtr:id>81a1488649be91d706a6fb1f2eea7f64</gtr:id><gtr:otherNames>Guthikonda K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1868-7075</gtr:issn><gtr:outcomeId>56d807223434c1.32204105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16B6D53C-0349-4FB7-81F6-FD804B5EA1C8</gtr:id><gtr:title>The effects on bronchial epithelial mucociliary cultures of coarse, fine, and ultrafine particulate matter from an underground railway station.</gtr:title><gtr:parentPublicationTitle>Toxicological sciences : an official journal of the Society of Toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d199504163267f11ec905f391f0c4525"><gtr:id>d199504163267f11ec905f391f0c4525</gtr:id><gtr:otherNames>Loxham M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1096-0929</gtr:issn><gtr:outcomeId>56d8029a8a2061.83212986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC26167C-6BCF-4901-BD2E-351CFD8D1DFC</gtr:id><gtr:title>The Study Team for Early Life Asthma Research (STELAR) consortium 'Asthma e-lab': team science bringing data, methods and investigators together.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6d39f523e43fc032d08526f1c4d4c7c"><gtr:id>c6d39f523e43fc032d08526f1c4d4c7c</gtr:id><gtr:otherNames>Custovic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>56d80721a7c815.98217629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E4FA392-8135-4A3E-8A7A-5B11BF4C0BF2</gtr:id><gtr:title>CaMKII is essential for the proasthmatic effects of oxidation.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72a65512d5a2598f4d6152170ee465bc"><gtr:id>72a65512d5a2598f4d6152170ee465bc</gtr:id><gtr:otherNames>Sanders PN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>pm_15040_20_23884469</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E95D925-7343-4907-9B6E-E2850458946E</gtr:id><gtr:title>Multidimensional endotypes of asthma: topological data analysis of cross-sectional clinical, pathological, and immunological data</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a45d701f4ef5ee26a6abcbf67e73393"><gtr:id>7a45d701f4ef5ee26a6abcbf67e73393</gtr:id><gtr:otherNames>Hinks T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d81189d67e92.83652075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88763B4B-DE97-4F5A-AF84-CD2ADB49755D</gtr:id><gtr:title>Resistin-like molecule-? is induced following bronchoconstriction of asthmatic airways.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26e8166ed388165d7a3225ca24890017"><gtr:id>26e8166ed388165d7a3225ca24890017</gtr:id><gtr:otherNames>Grainge C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>pm_15040_20_22758223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7006181-F13A-4245-AC5B-5862FDA55930</gtr:id><gtr:title>The relationship between infant lung function and the risk of wheeze in the preschool years.</gtr:title><gtr:parentPublicationTitle>Pediatric pulmonology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/781a1f27f0b2993c73d0e8bf51f7500f"><gtr:id>781a1f27f0b2993c73d0e8bf51f7500f</gtr:id><gtr:otherNames>Pike KC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1099-0496</gtr:issn><gtr:outcomeId>56d807256a1137.21440863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BCA3AF7-8436-4D03-8FF0-EEFE8084F4EB</gtr:id><gtr:title>Epithelial injury and repair in airways diseases.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b31ee767a89f08cb389e49db9b828f4"><gtr:id>6b31ee767a89f08cb389e49db9b828f4</gtr:id><gtr:otherNames>Grainge CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>54620a8e1d05e1.29032378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8F75EAD-8855-42FE-ADEF-028750894790</gtr:id><gtr:title>The innate antiviral response upregulates IL-13 receptor a2 in bronchial fibroblasts.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c266e75a45719efdd289278d39101679"><gtr:id>c266e75a45719efdd289278d39101679</gtr:id><gtr:otherNames>Campbell-Harding G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_15040_20_23069489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77F14709-4D47-474B-969B-2A874502077F</gtr:id><gtr:title>A microRNA network dysregulated in asthma controls IL-6 production in bronchial epithelial cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/454bfcc6b86e69fa0e13f05b526dd3e9"><gtr:id>454bfcc6b86e69fa0e13f05b526dd3e9</gtr:id><gtr:otherNames>Martinez-Nunez RT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5461fc7e73a1b6.94642115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ABEAE31-DDF8-4226-8743-446370961047</gtr:id><gtr:title>Staphylococcus aureus enterotoxin-specific IgE is associated with asthma in the general population: a GA(2)LEN study.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f93698f24f57716395a2f6a4b8d09959"><gtr:id>f93698f24f57716395a2f6a4b8d09959</gtr:id><gtr:otherNames>Tomassen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>56d8118ade3411.81148439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C1A6A4D-53A1-4D8B-A292-E97A8184861A</gtr:id><gtr:title>Does allergy begin in utero?</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/989c0969dbfc220550585e806f7e9ad6"><gtr:id>989c0969dbfc220550585e806f7e9ad6</gtr:id><gtr:otherNames>Lockett GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn><gtr:outcomeId>56d809a4e43729.66505633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09225131-D494-4A19-81B9-484F969C6F62</gtr:id><gtr:title>Inhibition of Pim1 kinase reduces viral replication in primary bronchial epithelial cells.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65b8b29f020f7dd8e84f7aef4217a59a"><gtr:id>65b8b29f020f7dd8e84f7aef4217a59a</gtr:id><gtr:otherNames>de Vries M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>5675e0753bad0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3D39D99-7567-444A-A1D7-1649FF3363CE</gtr:id><gtr:title>IL-1a mediates cellular cross-talk in the airway epithelial mesenchymal trophic unit.</gtr:title><gtr:parentPublicationTitle>Tissue barriers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5397a69022a7a6256a8e3599e475afa"><gtr:id>c5397a69022a7a6256a8e3599e475afa</gtr:id><gtr:otherNames>Hill AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-8362</gtr:issn><gtr:outcomeId>58c12caa5c2c79.83771671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46A64188-CBD4-4DD2-BE73-131F0E85E972</gtr:id><gtr:title>TNF-a-mediated bronchial barrier disruption and regulation by src-family kinase activation.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b69b12188dfea44a3cda6a72e268d1e"><gtr:id>9b69b12188dfea44a3cda6a72e268d1e</gtr:id><gtr:otherNames>Hardyman MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_15040_20_23632299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB14645D-B1CB-40D0-BE2C-C2C30C619A58</gtr:id><gtr:title>Experimental rhinovirus 16 infection in moderate asthmatics on inhaled corticosteroids.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc3658007df1ae4456b0af538bf72a9b"><gtr:id>bc3658007df1ae4456b0af538bf72a9b</gtr:id><gtr:otherNames>Adura PT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>56d807246c2ba9.99409157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29F5E5D5-E0ED-4F95-BFD2-E3B62F747AF8</gtr:id><gtr:title>Effects of phthalate exposure on asthma may be mediated through alterations in DNA methylation.</gtr:title><gtr:parentPublicationTitle>Clinical epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c63faa3053a23284b74025f5e4f85bfa"><gtr:id>c63faa3053a23284b74025f5e4f85bfa</gtr:id><gtr:otherNames>Wang IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1868-7075</gtr:issn><gtr:outcomeId>56d809a545c774.95328096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC14174B-9344-4F32-8892-6BA49A3FCA64</gtr:id><gtr:title>Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c17f1766cece5eb42cae7a706e8819e4"><gtr:id>c17f1766cece5eb42cae7a706e8819e4</gtr:id><gtr:otherNames>Nwokoro C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>56d809a5873008.35368997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FA46E5C-9B83-4D80-A416-D0805C09279C</gtr:id><gtr:title>The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15ffe01de4aa7447e44915fb0618fce1"><gtr:id>15ffe01de4aa7447e44915fb0618fce1</gtr:id><gtr:otherNames>Fleming L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>56d80723cbe8b1.33213597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE00D15F-577E-4ADF-B873-7B282637650E</gtr:id><gtr:title>Allergenic proteases cleave the chemokine CX3CL1 directly from the surface of airway epithelium and augment the effect of rhinovirus.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d199504163267f11ec905f391f0c4525"><gtr:id>d199504163267f11ec905f391f0c4525</gtr:id><gtr:otherNames>Loxham M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>5aa7c607c12299.38728116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4DB3CEF-BCEA-4F02-987C-8617856EB530</gtr:id><gtr:title>Changing prevalence of wheeze, rhinitis and allergic sensitisation in late childhood: findings from 2 Isle of Wight birth cohorts 12 years apart.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29b24514be53daa72546a54842fe018a"><gtr:id>29b24514be53daa72546a54842fe018a</gtr:id><gtr:otherNames>Patil VK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>56d8072179c5f6.40102166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBDA80FA-7388-479B-92D2-838EDE5B700B</gtr:id><gtr:title>Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology.</gtr:title><gtr:parentPublicationTitle>ALTEX</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf2c00f2432c5946fa8f46721989ed31"><gtr:id>cf2c00f2432c5946fa8f46721989ed31</gtr:id><gtr:otherNames>Gordon S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1868-596X</gtr:issn><gtr:outcomeId>56d94e605b2099.06109642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DAA24FA-662D-4848-A36E-BAB0800A37EE</gtr:id><gtr:title>The relationship between maternal adiposity and infant weight gain, and childhood wheeze and atopy.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/781a1f27f0b2993c73d0e8bf51f7500f"><gtr:id>781a1f27f0b2993c73d0e8bf51f7500f</gtr:id><gtr:otherNames>Pike KC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>56d80725432513.20321245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86245820-3D63-47B4-801A-0A23B8D23842</gtr:id><gtr:title>Epigenomics and allergic disease.</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/989c0969dbfc220550585e806f7e9ad6"><gtr:id>989c0969dbfc220550585e806f7e9ad6</gtr:id><gtr:otherNames>Lockett GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>56d809a602b4c9.08145112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76CCE614-7F4E-40C3-AC70-7877A3987D2A</gtr:id><gtr:title>Using genetics to predict the natural history of asthma?</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28951db76a9f81ac234722613fce9583"><gtr:id>28951db76a9f81ac234722613fce9583</gtr:id><gtr:otherNames>Holloway JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56d80723a58101.62212584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6204F65-0CC9-4D84-8E33-16669670FD1F</gtr:id><gtr:title>Altered Epithelial Gene Expression in Peripheral Airways of Severe Asthma.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8fac5a1f8cc08d60fcad4a7867269b3"><gtr:id>c8fac5a1f8cc08d60fcad4a7867269b3</gtr:id><gtr:otherNames>Singhania A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c15a8f511918.05391982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44C585E4-7475-4E5F-A188-780AE5E1DD86</gtr:id><gtr:title>Identification of host miRNAs that may limit human rhinovirus replication.</gtr:title><gtr:parentPublicationTitle>World journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5454fa5e37734f2709600bf536cd165"><gtr:id>f5454fa5e37734f2709600bf536cd165</gtr:id><gtr:otherNames>Bondanese VP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1949-8454</gtr:issn><gtr:outcomeId>56d95015670814.46531944</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A9A88D1-7F60-4C8E-8ACC-135CD5E094BA</gtr:id><gtr:title>Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4ffde7d1677ffe2c4313033fb3809be"><gtr:id>f4ffde7d1677ffe2c4313033fb3809be</gtr:id><gtr:otherNames>Bachert C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56d8118b910796.98067915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC75C93C-1AA7-4029-BFD2-FE910F23AD49</gtr:id><gtr:title>Identifying the heterogeneity of young adult rhinitis through cluster analysis in the Isle of Wight birth cohort.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d92a2783b2545da8dbff77ce303b028"><gtr:id>7d92a2783b2545da8dbff77ce303b028</gtr:id><gtr:otherNames>Kurukulaaratchy RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56d807225ea3f1.45101208</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>369A6FA5-7410-4D29-B49B-5EAB8C99EE2F</gtr:id><gtr:title>Transforming growth factor-beta promotes rhinovirus replication in bronchial epithelial cells by suppressing the innate immune response.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1372d4ee920433b8a2b50cf460d4832"><gtr:id>b1372d4ee920433b8a2b50cf460d4832</gtr:id><gtr:otherNames>Bedke N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15040_20_22970254</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDCA460B-6E77-42DF-A124-DA4B32E4F776</gtr:id><gtr:title>Allergy to furry animals: New insights, diagnostic approaches, and challenges.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/362a739e9c1090594b85bda766a96a9b"><gtr:id>362a739e9c1090594b85bda766a96a9b</gtr:id><gtr:otherNames>Konradsen JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56d80723f2ca74.88336969</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBE894BA-AA9D-459A-8055-197959BBA8CD</gtr:id><gtr:title>Modulation of Human Airway Barrier Functions during Burkholderia thailandensis and Francisella tularensis Infection Running Title: Airway Barrier Functions during Bacterial Infections.</gtr:title><gtr:parentPublicationTitle>Pathogens (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b9d2cf18d6caad596bebc041d226187"><gtr:id>2b9d2cf18d6caad596bebc041d226187</gtr:id><gtr:otherNames>Blume C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2076-0817</gtr:issn><gtr:outcomeId>58c15a8fb3cb90.93672352</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F44053B3-E4FA-433F-8673-29105E6AC23C</gtr:id><gtr:title>Asthmatic and normal respiratory epithelial cells respond differently to mechanical apical stress.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26e8166ed388165d7a3225ca24890017"><gtr:id>26e8166ed388165d7a3225ca24890017</gtr:id><gtr:otherNames>Grainge C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>56d8118a635284.58755281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5471C36-7192-4492-A44F-23D9D46D85D8</gtr:id><gtr:title>Frequent exacerbators--a distinct phenotype of severe asthma.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68f8911acbcaac1064aab25c5d932931"><gtr:id>68f8911acbcaac1064aab25c5d932931</gtr:id><gtr:otherNames>Kupczyk M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>5461f97341c1b1.42896094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF66C572-4C19-4CAA-AA03-D6157C8F8BE2</gtr:id><gtr:title>A new era of targeting the ancient gatekeepers of the immune system: toll-like agonists in the treatment of allergic rhinitis and asthma.</gtr:title><gtr:parentPublicationTitle>International archives of allergy and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4579529fcf879fb044d5def752a98c21"><gtr:id>4579529fcf879fb044d5def752a98c21</gtr:id><gtr:otherNames>Aryan Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1018-2438</gtr:issn><gtr:outcomeId>5461facb157fb3.30010750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B0A3ECE-7271-4C44-965F-A6F64C3296DB</gtr:id><gtr:title>Epithelial barrier function and immunity in asthma.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c22f80cc8dda3ef4f676f9f68ad44d8"><gtr:id>7c22f80cc8dda3ef4f676f9f68ad44d8</gtr:id><gtr:otherNames>Davies DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>5675ddf8be3bd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7C2439C-A6FD-47DA-A793-9C5873395ADB</gtr:id><gtr:title>Airway epithelial transcription factor NK2 homeobox 1 inhibits mucous cell metaplasia and Th2 inflammation.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89d7a566700b631a113c361e9329c959"><gtr:id>89d7a566700b631a113c361e9329c959</gtr:id><gtr:otherNames>Maeda Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>56d8118c49be59.59384388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B3E95ED-D59C-4D0B-816A-CA4D795679F5</gtr:id><gtr:title>Mechanical Strain Causes Adaptive Change in Bronchial Fibroblasts Enhancing Profibrotic and Inflammatory Responses.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df6218fdbbdd96ccbd9e67e22d1b5ae3"><gtr:id>df6218fdbbdd96ccbd9e67e22d1b5ae3</gtr:id><gtr:otherNames>Manuyakorn W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d506324eb14.76902002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>158FB761-83DC-4AD8-B593-E203D23D9C7F</gtr:id><gtr:title>Cigarette smoke causes caspase-independent apoptosis of bronchial epithelial cells from asthmatic donors.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2462c435ef89e2dc95f084e2d25d0745"><gtr:id>2462c435ef89e2dc95f084e2d25d0745</gtr:id><gtr:otherNames>Bucchieri F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d94f1249e745.07571081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C04B756-D820-4C2C-AF59-BCC037D2FDF4</gtr:id><gtr:title>Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf0c000b9d5c64008d02956db90edd5"><gtr:id>edf0c000b9d5c64008d02956db90edd5</gtr:id><gtr:otherNames>Pavord I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>56d8118b106c65.45855098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BCAF384-1104-458E-94CE-7BC35F336458</gtr:id><gtr:title>The effect of inhaled IFN-? on worsening of asthma symptoms caused by viral infections. A randomized trial.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d86690ebcc2d5e9359a3cc61c0e832ea"><gtr:id>d86690ebcc2d5e9359a3cc61c0e832ea</gtr:id><gtr:otherNames>Djukanovic R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>5461fb0402c723.89326306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A50F1D36-702F-4310-957E-2B3942CB3FB8</gtr:id><gtr:title>Airway Surfactant Protein D Deficiency in&amp;nbsp;Adults With Severe Asthma.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9816904a61f2484a4c84c02c6f583689"><gtr:id>9816904a61f2484a4c84c02c6f583689</gtr:id><gtr:otherNames>Mackay RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>56d80e9f415743.70381242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D61F384E-4469-49E9-8F15-CA9378F34574</gtr:id><gtr:title>Functional characterization of a novel 3D model of the epithelial-mesenchymal trophic unit.</gtr:title><gtr:parentPublicationTitle>Experimental lung research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2462c435ef89e2dc95f084e2d25d0745"><gtr:id>2462c435ef89e2dc95f084e2d25d0745</gtr:id><gtr:otherNames>Bucchieri F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0190-2148</gtr:issn><gtr:outcomeId>5aa7c6e9880781.92886356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDAEEB62-A185-4C7A-8EE0-3EEA9124F39E</gtr:id><gtr:title>Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/120396197daed2aafc88b77aa88f1912"><gtr:id>120396197daed2aafc88b77aa88f1912</gtr:id><gtr:otherNames>Hinks TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56d8118a380842.68166897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB359E1C-2687-4070-99C0-64C96F904E2A</gtr:id><gtr:title>Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.</gtr:title><gtr:parentPublicationTitle>International archives of allergy and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2b214240f28257b982cc90f67711634"><gtr:id>b2b214240f28257b982cc90f67711634</gtr:id><gtr:otherNames>WHO Collaborating Center for Asthma and Rhinitis</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1018-2438</gtr:issn><gtr:outcomeId>56d8118bea6cf2.64970262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A5DE78C-7687-4703-8C01-3FDC1DB2D313</gtr:id><gtr:title>Early growth characteristics and the risk of reduced lung function and asthma: A meta-analysis of 25,000 children.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/362959862457c8d0fd382a145a2450c6"><gtr:id>362959862457c8d0fd382a145a2450c6</gtr:id><gtr:otherNames>den Dekker HT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56d80721301ea6.72235313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41552E79-7F91-45B8-951C-8AC16E81C64B</gtr:id><gtr:title>Salbutamol but not ipratropium abolishes leukotriene D4-induced gas exchange abnormalities in asthma.</gtr:title><gtr:parentPublicationTitle>European journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ab0e41b66eb1d5fc9356eb298039fdc"><gtr:id>1ab0e41b66eb1d5fc9356eb298039fdc</gtr:id><gtr:otherNames>Dahl?n B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0031-6970</gtr:issn><gtr:outcomeId>56d8118bb70eb3.91199391</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3006D43-A96D-4205-BF3E-A93CF5B21F50</gtr:id><gtr:title>Nanomechanical assessment of human and murine collagen fibrils via atomic force microscopy cantilever-based nanoindentation.</gtr:title><gtr:parentPublicationTitle>Journal of the mechanical behavior of biomedical materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f613c8710a83a1650257a70e25afa3c1"><gtr:id>f613c8710a83a1650257a70e25afa3c1</gtr:id><gtr:otherNames>Andriotis OG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1878-0180</gtr:issn><gtr:outcomeId>546092b543aa87.89196957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50C44F07-62D9-472D-8BA5-DA7C4B0BA2A8</gtr:id><gtr:title>Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95863687bb1f6112d0742a9ecfcfca46"><gtr:id>95863687bb1f6112d0742a9ecfcfca46</gtr:id><gtr:otherNames>Uller L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>56d80e9fd61060.75723344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DA6D97E-4ACF-4A1C-A12C-BEEF92C2E218</gtr:id><gtr:title>Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK).</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b1d28acfed61c9b1b3cab0ed10cce6c"><gtr:id>0b1d28acfed61c9b1b3cab0ed10cce6c</gtr:id><gtr:otherNames>Heaney LG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>56d8118a0ff9d4.21643476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68434A7E-C646-486D-91C0-47A2E1EC0C23</gtr:id><gtr:title>Prenatal development is linked to bronchial reactivity: epidemiological and animal model evidence.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/781a1f27f0b2993c73d0e8bf51f7500f"><gtr:id>781a1f27f0b2993c73d0e8bf51f7500f</gtr:id><gtr:otherNames>Pike KC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56d809a5c91f04.23134776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AEB8D73-6DD3-478E-8A5D-8FF013AF6229</gtr:id><gtr:title>Genome-wide association studies in asthma; perhaps, the end of the beginning.</gtr:title><gtr:parentPublicationTitle>Current opinion in allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/989c0969dbfc220550585e806f7e9ad6"><gtr:id>989c0969dbfc220550585e806f7e9ad6</gtr:id><gtr:otherNames>Lockett GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-6322</gtr:issn><gtr:outcomeId>56d809a6305807.88279129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADB85252-1B07-4230-9C5C-505292E2D728</gtr:id><gtr:title>Developmental determinants in non-communicable chronic diseases and ageing.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f59e58738a90493179d2cbcfa849c8f"><gtr:id>0f59e58738a90493179d2cbcfa849c8f</gtr:id><gtr:otherNames>Bousquet J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>56d8072208f1f9.70744751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4882D6F9-D893-4165-8E45-A278378737AC</gtr:id><gtr:title>Soluble ADAM33 initiates airway remodeling to promote susceptibility for allergic asthma in early life.</gtr:title><gtr:parentPublicationTitle>JCI insight</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08b5309dde4cf0034e1f18ad3741e703"><gtr:id>08b5309dde4cf0034e1f18ad3741e703</gtr:id><gtr:otherNames>Davies ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2379-3708</gtr:issn><gtr:outcomeId>58c15a900182e7.99560650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A433B09F-7B81-4401-8714-50B0B4D9993C</gtr:id><gtr:title>The relation of airway obstruction to asthma, chronic rhinosinusitis and age: results from a population survey of adults.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93e153d1d0312bc3bb32d9f21784c8e4"><gtr:id>93e153d1d0312bc3bb32d9f21784c8e4</gtr:id><gtr:otherNames>Obaseki D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>56d8118a8c4086.74808554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE53AEDA-0A18-4D79-BCB5-0D25D03C232F</gtr:id><gtr:title>Tumor necrosis factor alpha (TNF-a) autoregulates its expression and induces adhesion molecule expression in asthma.</gtr:title><gtr:parentPublicationTitle>Clinical immunology (Orlando, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd7bdb6bd19b3a45ae9ef0efe392106c"><gtr:id>cd7bdb6bd19b3a45ae9ef0efe392106c</gtr:id><gtr:otherNames>Babu SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1521-6616</gtr:issn><gtr:outcomeId>56d8072350d5a9.82123075</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900453</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>